OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 66 filers reported holding OCULAR THERAPEUTIX INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,000 | +100.0% | 700 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | +50.0% | 700 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 700 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 700 | -50.0% | 0.00% | – |
| Q4 2017 | $6,000 | +50.0% | 1,400 | +100.0% | 0.00% | – |
| Q3 2017 | $4,000 | -33.3% | 700 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | -68.4% | 700 | -68.2% | 0.00% | -100.0% |
| Q4 2016 | $19,000 | 0.0% | 2,200 | -18.5% | 0.00% | 0.0% |
| Q3 2016 | $19,000 | +533.3% | 2,700 | +285.7% | 0.00% | – |
| Q2 2016 | $3,000 | -57.1% | 700 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |